Useful information on how to submit a research article
RESEARCH ARTICLE FORMAT
Each presenter planning to give a PowerPoint® and/or a poster presentation at the conference is strongly encouraged to submit a research article (up to six letter-sized pages) for publication in the Proceedings. Each research article must be prepared according to these guidelines so that the Proceedings can be peer-reviewed and published in a rapid, timely manner. Questions about this submittal process can be sent to firstname.lastname@example.org
REQUIREMENTS FOR PUBLICATION
The Proceedings will serve as a permanent record of the material presented at the conference. To ensure maximum currency of the information and availability soon after the conference, a tight schedule must be followed.
The deadline has been set at the latest possible that will still allow each submission to be reviewed, compiled into volumes and printed. Submissions must arrive in electronic form, be 4-6 pages in length, pass the review process, and satisfy the format specifications below. Any submission that does not fulfill all requirements will be subject to rejection. In such cases, only titles, authors and abstracts will be published in the proceedings. Hard copies of a paper manuscript will not be accepted for publication.
Each author should make reasonable efforts to ensure that the submitted manuscript/s comply with the ethical standards as described here.
Manuscripts shall be prepared according to the Author Instructions as described here.
Each manuscript shall be be accompanied by a TCA form.
Learn how to prepare manuscripts for submission to AIP Journals here.
Feel free to send your questions to email@example.com
Funding for this conference was made possible, in part, by the Food and Drug Administration through Grant # 1 R13 FD003707-01. The views expressed in written conference materials or publications and by speakers and moderators do not necessarely reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organization imply endorsement by the U.S. Government. This conference was supported by FDAIR13 FD003797.
Contact BioNanoTox at (+1)501-569-3270 or firstname.lastname@example.org
Webdesign and maintenance by Guenther Duvall, Allyson Speech Labs, Brooklyn NY
Forward constructive suggestions for improvements to email@example.com